Search results
Ionis (IONS), AstraZeneca's Amyloidosis Drug Meets Study Goals
Zacks via Yahoo Finance· 2 years agoIonis (IONS), along with partner AstraZeneca, reports positive data from a phase III study, which is...
Ionis (IONS) Q4 Loss Narrower Than Expected, Sales Surge Y/Y
Zacks via Yahoo Finance· 3 months agoIonis Pharmaceuticals IONS reported a loss of 6 cents per share for fourth-quarter 2023, which was...
Ionis (IONS) Q2 Earnings & Sales Miss Estimates, Stock Down
Zacks via Yahoo Finance· 2 years agoIonis Pharmaceuticals IONS reported second-quarter 2022 loss of 74 cents per share, which was wider...
Ionis (IONS) Q2 Loss Narrows Y/Y, Sales Surpass Estimates
Zacks via Yahoo Finance· 9 months agoIonis Pharmaceuticals IONS reported a loss of 60 cents per share for second-quarter 2023, which was...
Ionis' (IONS) Olezarsen Gets FDA's Orphan Tag for Rare Disease
Zacks via Yahoo Finance· 3 months agoFDA grants orphan drug status to Ionis' (IONS) olezarsen for treating familial chylomicronemia...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript August 9, 2023 Ionis...
Ionis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs
Zacks via Yahoo Finance· 8 months agoPer the agreement, Ionis (IONS) will grant exclusive global rights to Roche to develop and market...
Ionis' (IONS) Hypercholesterolemia Drug Not to Enter Phase III
Zacks via Yahoo Finance· 2 years agoIonis (IONS) posts data from the phase IIb SOLANO study on ION449 for treating hypercholesterolemia....
Ionis (IONS) Posts Two-Year Upbeat Data From HAE Drug Study
Zacks via Yahoo Finance· 12 months agoData from a mid-stage study shows that treatment with Ionis' (IONS) donidalorsen over a two-year...
13 Most Undervalued Pharma Stocks To Buy According To Analysts
Insider Monkey via Yahoo Finance· 7 months agoIn this piece, we will take a look at the 13 most undervalued pharmaceutical stocks to buy according...